Viatris (VTRS) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.
Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Sale Paul Campbell, See Remarks sold 50,076 shares at $16.17 ($810K).
- Trade date
- Jun 25, 2026
- Disclosed to the SEC
- Jun 26, 2026
- Type
- Pre-planned sale, 10b5-1 (code S)
Read the original SEC filing ↗All VTRS insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
VTRS insider transactions (Form 4)
Open-market purchases and sales. 96 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jun 26SEC | Paul CampbellSee Remarks | Sell Plan | 50,076316,212 held (−14%) | $16.17 | $810K | +23.2% | — |
| Mar 24SEC | Paul CampbellSee Remarks | Sell | 21,350366,288 held (−6%) | $13.28 | $284K | +50.0% | — |
| Mar 10SEC | David S. SimmonsDirectorFirst buy | Buy | 286970 held (+42%) | $10.42 | $3K | +91.1% | — |
| Mar 10SEC | David S. SimmonsDirectorFirst buyBefore earnings | Buy | 2131,183 held (+22%) | $10.43 | $2K | +91.1% | — |
Similar past setups: not applicable. VTRS has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with VTRS in the Research Lab
VTRS has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Viatris insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $1.1M of VTRS stock on the open market.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
VTRS insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $810K | 1 |
| Q1 2026 | — | 0 | $284K | 1 |
| Q4 2025 | $2K | 1 | — | 0 |
| Q3 2025 | $3K | 1 | — | 0 |
Valuation, profit and volume
Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Viatris insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $1.1M. Among insiders with enough purchase history to measure, James M. Kilts (Director) has the highest Insider Score at 100. 1 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
VTRS earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 6, 2026 | +0.3% | None | -6.9%S&P +0.5% | +3.5% |
| May 7, 2026 | +8.3% | None | +7.6%S&P +0.5% | -6.8% |
| Feb 26, 2026 | +0.8% | None | -7.2%S&P -1.0% | -11.8% |
| Nov 6, 2025 | +3.5% | None | -5.9%S&P -1.0% | +9.3% |
| Aug 7, 2025 | -5.3% | None | +10.9%S&P +0.7% | +9.5% |
| May 8, 2025 | +11.8% | None | +2.0%S&P +0.6% | +0.7% |
| Feb 27, 2025 | +5.9% | None | -17.9%S&P -0.1% | -4.8% |
| Nov 7, 2024 | -0.5% | None | +11.6%S&P +1.2% | -1.0% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
VTRS short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Insiders at Viatris
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Paul CampbellSee Remarks | — | $1.1M | Jun 26, 2026 | — | — |
| David S. SimmonsDirector | $5K | — | Mar 10, 2026 | — | — |
| Andrew EnriettiSee Remarks | — | — | Aug 18, 2026 | — | — |
| Goff Corinne LeChief Commercial Officer | — | — | Apr 16, 2026 | — | — |
| Scott Andrew SmithCEO | — | — | Mar 10, 2026 | — | — |
| Theodora MistrasCFO | — | — | Mar 10, 2026 | — | — |
| Leo Frans GroothuisDirector | — | — | Mar 10, 2026 | — | — |
| Elisha W. FinneyDirector | — | — | Mar 10, 2026 | — | — |
| W. Don CornwellDirector | — | — | Mar 10, 2026 | — | — |
| Frank A. DamelioDirector | — | — | Mar 10, 2026 | — | — |
| Dillon Joellen LyonsDirector | — | — | Mar 10, 2026 | — | — |
| Melina E. HigginsDirector | — | — | Mar 10, 2026 | — | — |
| Richard A. MarkDirector | — | — | Mar 10, 2026 | — | — |
| Mark W. ParrishDirector | — | — | Mar 10, 2026 | — | — |
| Michael SeverinoDirector | — | — | Mar 10, 2026 | — | — |
| Coelho Rogerio VivaldiDirector | — | — | Mar 10, 2026 | — | — |
| James M. KiltsDirector | — | — | Mar 10, 2026 | 8 of 12 | 100 |
Board links: companies that share insiders with VTRS
Directors and executives who filed Form 4s for VTRS and another company in the last 12 months.
- ADVAdvantage Solutions James M. Kilts Director here · Director at ADV · latest filing Mar 24, 2026
- EWEdwards Lifesciences Theodora Mistras CFO here · CFO at EW · latest filing Jul 10, 2026
- HPEHewlett Packard Enterprise Frank A. Damelio Director here · Director at HPE · latest filing Apr 3, 2026
- ICUIIcu Medical Elisha W. Finney Director here · Director at ICUI · latest filing Nov 13, 2026
- MTDMettler Toledo Elisha W. Finney Director here · Director at MTD · latest filing Nov 12, 2026
- SMPLSimply Good Foods James M. Kilts Director here · Director at SMPL · latest filing Apr 24, 2026
- ZTSZoetis Frank A. Damelio Director here · Director at ZTS · latest filing Aug 11, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
VTRS stock: common questions
Are Viatris insiders buying VTRS stock?
No. No Viatris insider reported an open-market purchase of VTRS in the past 12 months. The latest was Director David S Simmons bought $3K of VTRS at $10.42 — first open-market purchase in our records; raises the stake by 42%.
Are Viatris insiders selling VTRS stock?
1 insider reported sales worth $1.1M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is VTRS's 52-week range?
Over the past year VTRS has traded between $9.84 and $21.06. It last closed at $19.92 on Nov 19, 2026.